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Background: Genetic information given to an individual newly diagnosed with a genetic condition is likely to have
important health implications for other family members. The task of communicating with these relatives commonly
falls to the newly diagnosed person. Talking to relatives about genetic information can be challenging and is
influenced by many factors including family dynamics. Research shows that many relatives remain unaware of
relevant genetic information and the possible impact on their own health. This study aims to evaluate whether a
specific genetic counselling intervention for people newly diagnosed with a genetic condition, implemented over
the telephone on a number of occasions, could increase the number of at-risk relatives who make contact with
genetics services after a new genetic diagnosis within a family.
Methods: This is a prospective, multi-centre randomised controlled trial being conducted at genetics clinics at five
public hospitals in Victoria, Australia. A complex genetic counselling intervention has been developed specifically
for this trial. Probands (the first person in a family to present with a diagnosis of a genetic condition) are being
recruited and randomised into one of two arms – the telephone genetic counselling intervention arm and the
control arm receiving usual care. The number of at-risk relatives for each proband will be estimated from a family
pedigree collected at the time of diagnosis. The primary outcome will be measured by comparing the proportion
of at-risk relatives in each arm of the trial who make subsequent contact with genetics services.
Discussion: This study, the first randomised controlled trial of a complex genetic counselling intervention to enhance
family communication, will provide evidence about how best to assist probands to communicate important new
genetic information to their at-risk relatives. This will inform genetic counselling practice in the context of future
genomic testing.
Trial registration: Australia and New Zealand Clinical Trials Register (ANZCTR): ANZCTRN12608000642381.
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When an individual (proband) receives a new diagnosis
of a genetic condition for themselves or their child, the
genetic information often has implications for other
family members who may themselves be at risk of carrying
the same mutation. This means that they may develop the* Correspondence: jan.hodgson@mcri.edu.au
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their children.
Current local practice in state funded health services
in Victoria, Australia, in keeping with Victorian Privacy
laws, is for genetic health care providers to discuss with
the proband the importance of communicating the gen-
etic information to at-risk relatives and offer resources
such as letters or information sheets. The health care
provider, however, does not make direct contact with
relatives. Despite routine advice given to the proband
about the importance of communicating risk to relatives,al Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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tives remain unaware of the relevant genetic information
[1-3]. Several reasons have been identified for this failure
of family communication. First, genetic information is
often difficult to understand and to explain clearly, and
probands may lack knowledge or confidence in their
ability to communicate this information [4-6]. Further,
while probands frequently describe feeling a sense of
obligation about informing other at-risk relatives [7],
they may be reluctant to do so due to existing challenging
family dynamics and relationships [8,9]. Finally, probands
may wish to protect their family members from anxiety
[10-13] or they may be experiencing difficulties in coming
to terms with their own diagnosis, [1,14] making commu-
nication problematic.
Most knowledge of how families communicate genetic
information comes from research into families with
inherited cancers. It is recognised that probands fre-
quently deliberate about when may be an appropriate
time for their relatives to receive the genetic information
[15]. Women are more likely to communicate than men
[16] and, when communication occurs, it appears that
first-degree relatives are usually informed first and often
with an assumption that those who are informed will in
turn pass the information on to their close relatives [1].
When questioned about how communication of gen-
etic information should optimally occur, relatives believe
that it should be done by family members but supported
by genetic health professionals [12]. Health professionals
themselves have often debated whether they should take
a more active approach in informing possibly at-risk
family members about genetic information. Professional
guidelines encourage discussion of the importance of
family communication [17] and there have been some
attempts by genetics services to assist probands to do so
by asking for contact details and sending letters to
at-risk relatives on their behalf [18] or by use of a
genetic register [19].
Overall, it appears that probands require more assistance
to communicate genetic information effectively [6,20]. A
small study in Australia provided evidence that additional
genetic counselling support could result in a significant
increase (36-61%) in family communication, represented
by an increase in contact from at-risk family members
with genetics services [19].Presentation of the hypothesis
The aim of this multicentre randomised trial is to
investigate whether a specifically designed genetic coun-
selling intervention will result in increased access to
genetics services by at-risk family members, following
identification of a genetic condition or carrier status in
a proband.The main hypothesis is that a specifically designed
genetic counselling intervention delivered by phone at
three time points over 18 months will facilitate commu-
nication of important genetic information within fam-
ilies, thereby increasing the number of at-risk family
members who seek information and/or testing from
genetics services.
Testing the hypothesis
The following details are presented in accordance with
the CONSORT reporting guidelines for randomised tri-
als of non-pharmacologic treatment [21]. The following
Human Research Ethics Committees in Victoria, Australia
have all approved this project: Austin Health, Bendigo
Health, Ballarat Health, Royal Childrens Hospital,
Melbourne Health and Southern Health.
Participants
Inclusion criteria
Potential participants for this prospective, randomised
controlled trial must:
 be the first person in a family to be diagnosed, or
have a child diagnosed, with a genetic condition
about which the genetic information has
implications for other family members and for
which genetic testing or diagnosis based on clinical
information is possible
 be able to speak, read and write English
 have at least one at-risk relative who resides
in Victoria
 be aged 18 years or over.
Exclusion criteria
Potential participants are excluded if they:
 have a cognitive disorder that affects their ability to
give informed consent
 have received a diagnosis during pregnancy
 reside outside of Victoria.
Setting and locations
The trial is being conducted within genetic clinic set-
tings at six tertiary public hospitals in Victoria. These
sites were chosen on the basis of variation in client
populations and types of genetic diagnoses likely to be
made, as well as the presence of an experienced genetic
counsellor on staff.
Genetic counsellors performing the intervention
The 10 genetic counsellors in the study routinely dis-
close new genetic information to probands as part of
their clinical duties. Each genetic counsellor is either
fully certified or has a minimum of two years clinical
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training in delivering the genetic counselling interven-
tion and have access to an intervention protocol manual.
Study intervention
Development of the intervention was informed by a
framework for complex interventions [22]. This enabled
the intervention to incorporate the patient-centred ethos
and nondirective stance fundamental to genetic counsel-
ling practice with a process that is standardised and can
be replicated. The intervention was designed to use
genetic counselling strategies to address documented
personal barriers to family communication. The Reciprocal
Engagement Model [23] is the model of genetic counsel-
ling practice applied in the intervention, while evidence for
barriers was taken from a systematic literature review [1].
The counselling framework for the intervention has
three domains; the focus on each is determined by the
participant’s needs over time. These are:
 “Getting the picture” about the participant’s
experiences of communication to date, including:
which relatives have been informed and their
responses; recognising and exploring the conscious
and unconscious barriers to communication;
supporting adjustment of the participant to their
own genetic status.
 Forming an intention to act. This includes
maintaining or enhancing the participant’s capacity
for communication; facilitating decision-making; and
resolving ambivalence.
 Planning to act. Here the participant intends to
communicate, options are elicited, a plan developed
and potential scenarios explored to prepare the
participant.
The intervention was designed to be feasible to imple-
ment in clinical practice, as an adjunct to usual care [24].
To further emulate the ‘real world setting’ the inter-
vention is delivered by the same genetic counsellor that
each participant met at their visit to the genetics clinic.
Intervention phone calls are audiotaped and analysed
to examine adherence to the intervention protocol. Such
monitoring of the intervention fidelity ensures its deliv-
ery and receipt is as intended.
Process
At the time of their initial genetic consultation all pro-
bands receive standard care concerning family commu-
nication from the genetic counsellor. This generally
involves a discussion of possible implications for other
family members and the offer of explanatory letters for
the proband to pass on to at-risk relatives Probands
are informed about the research study by the geneticcounsellor at the end of this consultation. If they con-
sent, their contact details are faxed to the research team
for recruitment to proceed. A researcher then contacts
potential participants by telephone to explain the project
and the possibility that they may receive follow-up
telephone calls (if in the intervention arm). Written
informed consent is requested by mail and, once re-
ceived, participants are randomised into the intervention
or control group.
Participants who are randomised into the control
group receive no further contact specific to family
communication.
Participants in the intervention group receive standard
care plus three intervention phone calls from a genetic
counsellor delivered over the subsequent 12 months.
Outcomes
Primary – measurement of uptake of genetic services
The number of at-risk relatives is ascertained from three
generation pedigrees collected by the genetic counsellors
at the time of diagnosis for all participants and held in
the family Genetics Files. Eighteen months after the pro-
band attends the genetic clinic and is enrolled in the
study, the family file is audited to determine the actual
number of at-risk relatives who make contact with
Victorian genetic clinics.
The total number of at-risk relatives who have contact
with a genetics service divided by the total number of
at-risk relatives gives a percent that can be compared
between the two arms of the study. A person’s ‘at-risk
status’ is based on genetic relatedness, taking into ac-
count the inheritance pattern for the condition involved.
During the study there may be further clarification of
the at-risk status. For example, a negative genetic test
result for an autosomal recessive condition in one family
member means that the mutation will not be further
transmitted in that branch of the family. Therefore, the
original estimate of the number of ‘at-risk’ relatives will
be reduced accordingly. Relatives who live overseas or
interstate are excluded from the analysis as we are
unable to document their uptake of genetics services.
All data are managed in ACCESS database, 2007
version.
Secondary – follow-up telephone interview to assess
participant experiences
At the 18 month exit point of the study, participants are
telephoned to complete a structured survey assessing
their experiences of family communication and partici-
pation in a RCT. This identifies differences in attitudes,
awareness and suggestions for best practice between the
two groups. This survey has been developed using a
Delphi process involving the study team and both expe-
rienced and student genetic counsellors. It focuses on:
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at-risk family members
 experience of informing family members
 which family members were informed and when
 the barriers and facilitators to communication
 professional support that is helpful and acceptable
to families
 other suggestions for practice.
In addition, the genetic counsellors who delivered the
intervention will be interviewed in a focus group setting
to reflect on their experience of participation.
A further sub-study to assess fidelity will examine
the intervention phone calls to determine counsellors’
adherence to the intervention protocol.Sample size
We aim to detect a difference of at least 15% in contact
with a genetic service (e.g. 20% of relatives in the control
group, 35% in the intervention group). A sample size of
151 at-risk relatives per group has 80% power to detect
this difference (with an alpha level of 0.05) if all the
at-risk relatives were independent of each other; that is,
if the clustering of at-risk relatives is ignored. Data from
a preliminary study in Tasmania suggest that there is an
average of seven at-risk relatives per proband. With a
conservative estimate of five at-risk relatives per pro-
band, a sample size of 151 at-risk relatives requires
participation of 30 probands [19].
Since is it probable that responses of at-risk relatives
of each proband are more similar to each other than to
relatives of other probands, the clustering effect must be
taken into account. The average degree of similarity to
be expected between at-risk relatives of a given proband
(the intraclass correlation (ICC) is unknown as there
have been no similar studies. Data from community-
based surveys in the UK have shown that many ICCs for
households were in the range of 0.0 to 0.3 [25]. Assuming
an ICC of 0.25 and an average cluster size of 5, the Design
Effect (DE) would be 2 (DE = 1+ (cluster size −1)*ICC).
Thus, the required number of at-risk relatives in each
group is 302 (=151*2) necessitating a sample size of 60
probands in each arm. Given our conservative assumption
of five at-risk relatives per proband, this will detect a
difference of at least 15%. In addition, with attrition
rate of approximately 15% over the 18 month study
period, there is a need to recruit an extra 10 probands
for each arm (i.e. 70 probands per arm).
To allow for correlation between the likelihood of
making contact with a genetics service of relatives of the
same probands, the method of marginal logistic regression
models fitted using Generalised Estimating Equations
(GEEs) with information sandwich estimates of standarderror will be used to estimate the odds ratios between the
intervention and control arm for the primary outcome.
Randomisation
The randomisation sequence was constructed by the
Clinical Epidemiology and Biostatistics Unit (CEBU) at
the Murdoch Childrens Research Institute using Stata
11.0 (StataCorp, College Station, TX) statistical software.
A statistician in CEBU, who is independent of the study
investigators, retains the only copy of the randomisation
sequence, Randomisation is stratified by genetic counsellor,
allocation is 1:1 and random block sizes are used to ensure
concealment of allocation. After a participant is enrolled in
the study, the study co-ordinator contacts CEBU to obtain
the treatment allocation for that participant.
Implication of the hypothesis
Successful family communication about important gen-
etic information is dependent on a number of factors
including pre-existing family dynamics and an individ-
ual’s ability to give and receive complex genetic informa-
tion. This trial, of a genetic counselling intervention that
has been specifically designed to address potential bar-
riers to family communication, will provide evidence for
whether additional support by health professionals can
improve family communication about genetics.
A project steering committee meets monthly to over-
see the trial and ensure that it is being conducted rigor-
ously and in accordance with HREC requirements.
As recruitment for the trial is slower than had been
anticipated, a data collection form has been used for a
three month period to determine the eligibility of clients
being seen at each genetics clinic. This has enabled
documentation of reasons for non-participation and
those findings will be published separately.
Ascertaining whether family communication actually
takes place is problematic as it would be unethical and
not feasible to ask at-risk relatives directly whether they
have been informed of the presence of a genetic condi-
tion in the family. Therefore, it is important to note that
the primary outcome measure, the percent of family
members who actually make contact with Victorian
genetics services, is a ‘proxy’ measure and may not
reflect the true level of family communication that in
fact occurs.
Another possible reason that the primary outcome
might produce an under-representation of family com-
munication is that relatives may access genetic infor-
mation from agencies, individuals outside the scope of
this study, e.g. GPs, obstetricians or non-Victorian
genetic services. Given the randomised study design,
any such under-enumeration of the primary outcome
measure would be expected to be similar in both arms
of the study.
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arising from initiatives such as the Human Genome
Project combined with technological advances mean that
more people will receive definitive genetic diagnoses and
testing results. There is also a growing access to, and
demand for, genomic information originating outside the
clinic setting (e.g. direct-to-consumer testing), but lead-
ing to a need for genetic counselling [26]. Consequently,
the need for communication of this information within
families will become even more prevalent. We anticipate
that the findings of this study will assist in development
of new resources and enhance skills of health profes-
sionals who are required to assist in this process of
communication of genetic information in families.
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